Spots Global Cancer Trial Database for therapeutic estradiol

Every month we try and update this database with for therapeutic estradiol cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer	NCT01385280	Estrogen Recept... Progesterone Re... Recurrent Breas... Stage IIIC Brea... Stage IV Breast...	therapeutic est... exemestane laboratory biom... enzyme-linked i...	-	University of Arizona
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer	NCT03941730	Advanced Triple... Anatomic Stage ... Anatomic Stage ... Metastatic Trip... Recurrent Breas...	Biopsy Computed Tomogr... Magnetic Resona... Positron Emissi... Therapeutic Est...	18 Years -	Mayo Clinic
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer	NCT06179303	Anatomic Stage ... Anatomic Stage ... Locally Advance... Locally Advance... Metastatic HER2... Metastatic Horm...	Abemaciclib Anastrozole Biospecimen Col... Computed Tomogr... Diagnostic Imag... Exemestane Fludeoxyglucose... Fluorine F 18 F... Fulvestrant Gonadotropin-re... Letrozole Positron Emissi... Tamoxifen Therapeutic Est...	18 Years -	University of Washington
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer	NCT01385280	Estrogen Recept... Progesterone Re... Recurrent Breas... Stage IIIC Brea... Stage IV Breast...	therapeutic est... exemestane laboratory biom... enzyme-linked i...	-	University of Arizona
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer	NCT03941730	Advanced Triple... Anatomic Stage ... Anatomic Stage ... Metastatic Trip... Recurrent Breas...	Biopsy Computed Tomogr... Magnetic Resona... Positron Emissi... Therapeutic Est...	18 Years -	Mayo Clinic
Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer	NCT00003771	Breast Cancer Menopausal Symp...	therapeutic est... norethindrone a...	-	National Cancer Institute (NCI)
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer	NCT06179303	Anatomic Stage ... Anatomic Stage ... Locally Advance... Locally Advance... Metastatic HER2... Metastatic Horm...	Abemaciclib Anastrozole Biospecimen Col... Computed Tomogr... Diagnostic Imag... Exemestane Fludeoxyglucose... Fluorine F 18 F... Fulvestrant Gonadotropin-re... Letrozole Positron Emissi... Tamoxifen Therapeutic Est...	18 Years -	University of Washington
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease	NCT00080756	brca1 Mutation ... brca2 Mutation ... Breast Cancer	therapeutic est... deslorelin therapeutic tes... therapeutic con... active surveill... quality-of-life... laboratory biom...	21 Years - 48 Years	City of Hope Medical Center
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer	NCT01385280	Estrogen Recept... Progesterone Re... Recurrent Breas... Stage IIIC Brea... Stage IV Breast...	therapeutic est... exemestane laboratory biom... enzyme-linked i...	-	University of Arizona

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: